Literature DB >> 9916891

IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6.

A Armario1, J Hernández, H Bluethmann, J Hidalgo.   

Abstract

The role of interleukin-6 (IL-6) on emotional behavior was studied in two experiments using transgenic mice carrying a null mutation for IL-6 (IL-6(-/-)). In the first experiment, IL-6(-/-) mice were compared with the two wild-type strains contributing to the genetic background of the transgenic mice, namely C57BL/6J and 129/SvJ, as well as with the F2 offspring of C57BL/6J x 129/SvJ mice. The two parental strains differed substantially in terms of emotional reactivity, suggesting that the F2 offspring were more appropriated for analyzing the effect of the null mutation. IL-6(-/-) mice showed lower levels of ambulation in the holeboard, and lower levels of exploration of the open arms of the plus-maze, than the wild-type F2 C57BL/6J x 129/SvJ mice. In the second experiment, IL-6(-/-) mice were backcrossed for 10 generations to C57BL/6J mice to decrease the uncertainty of the effect of the genetic background, and when compared with wild-type C57BL/6J mice in the holeboard and the plus-maze, the same results were obtained. Therefore, IL-6(-/-) mice seem to be more emotional than their appropriate controls, suggesting that the major cytokine IL-6 is involved in the control of emotionality.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9916891     DOI: 10.1016/s0165-5728(98)00199-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

2.  Enduring influences of peripubertal/adolescent stressors on behavioral response to estradiol and progesterone in adult female mice.

Authors:  Julie Laroche; Lauren Gasbarro; James P Herman; Jeffrey D Blaustein
Journal:  Endocrinology       Date:  2009-04-16       Impact factor: 4.736

3.  Reduced behavioral response to gonadal hormones in mice shipped during the peripubertal/adolescent period.

Authors:  Julie Laroche; Lauren Gasbarro; James P Herman; Jeffrey D Blaustein
Journal:  Endocrinology       Date:  2009-01-08       Impact factor: 4.736

Review 4.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

5.  Induction of interleukin-6 by depolarization of neurons.

Authors:  S Sallmann; E Jüttler; S Prinz; N Petersen; U Knopf; T Weiser; M Schwaninger
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

6.  Reduced fear memory and anxiety-like behavior in mice lacking formylpeptide receptor 1.

Authors:  Ji-Liang Gao; Erich H Schneider; Eugene L Dimitrov; Forrest Haun; Therese M Pham; Abdul H Mohammed; Ted B Usdin; Philip M Murphy
Journal:  Behav Genet       Date:  2011-04-12       Impact factor: 2.805

7.  Characterization of the role of the antioxidant proteins metallothioneins 1 and 2 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Paul A Adlard; Ashley I Bush; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

Review 8.  Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

Authors:  Paula E Goines; Paul Ashwood
Journal:  Neurotoxicol Teratol       Date:  2012-08-17       Impact factor: 3.763

9.  Maternal immune activation alters fetal brain development through interleukin-6.

Authors:  Stephen E P Smith; Jennifer Li; Krassimira Garbett; Karoly Mirnics; Paul H Patterson
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

Review 10.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.